Ivan Wasserman helps food and dietary supplement producers, cosmetic businesses, drug companies and medical device manufacturers navigate the maze of laws and government agencies with regulatory authority over their products. He counsels these clients on issues related to product development, advertising and product labeling, and product safety and product recalls.
Many of Ivan’s clients are subject to the overlapping jurisdictions of the U.S. Food and Drug Administration and the Federal Trade Commission. He responds to FDA warning letters and FTC investigations, prepares 510(k) premarket notifications for medical devices, and advises clients on ingredient reviews and product formulation.
In addition, Ivan handles adverse event reporting and product recalls, prepares new dietary ingredient notifications for supplements, and addresses import detentions and product seizures.
For advertising clients, Ivan reviews advertising campaigns (including websites) for regulatory compliance, and helps gather the information necessary to substantiate advertising claims. In addition to representing clients on advertising matters before the FTC and FDA, he also has experience with proceedings before the National Advertising Division of the Council of Better Business Bureaus and the Electronic Retailing Self-Regulation Program.
Ivan also helps clients comply with U.S. Consumer Product Safety Commission labeling and reporting requirements, and works with clients to proactively respond when problems with products arise. He guides his clients through the process of recalling a product, while also working to minimize adverse publicity. He also handles CPSC investigations into whether companies complied with the reporting requirements of Section 15(b) of the Consumer Product Safety Act.
In addition to Ivan’s practice, he is the administrative partner for the D.C. office.